Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
Polo Kinase Phosphorylates Miro to Control ER-Mitochondria Contact Sites and Mitochondrial Ca2+ Homeostasis in Neural Stem Cell Development - ScienceDirect
Aurora B activity is required for the activation of Polo kinase at the... | Download Scientific Diagram
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
PLK1 - Wikipedia
Polo Like Kinase-enzyme
Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization | PNAS
Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS
The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? | Cancer Research
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
![PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fab03d33f093b807e4c4dea23eab368e3b4ae0c/3-Figure1-1.png "PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar")
PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar
Capturing Polo Kinase | Science
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia
A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key | Open Biology
Understanding the Polo Kinase machine | Oncogene
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis | HTML
Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research
Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma
Model for the interactions between the CPC and Polo kinase at the... | Download Scientific Diagram
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas | Oncology
Proline-Rich Motifs Control G2-CDK Target Phosphorylation and Priming an Anchoring Protein for Polo Kinase Localization. - Cell Rep. - X-MOL
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar
Polo-like kinases and the orchestration of cell division | Nature Reviews Molecular Cell Biology
